Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sotera Health (SHC) Capital Expenditures (2020 - 2025)

Historic Capital Expenditures for Sotera Health (SHC) over the last 6 years, with Q3 2025 value amounting to $36.2 million.

  • Sotera Health's Capital Expenditures fell 59.63% to $36.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $153.2 million, marking a year-over-year decrease of 1395.13%. This contributed to the annual value of $179.1 million for FY2024, which is 1670.19% down from last year.
  • According to the latest figures from Q3 2025, Sotera Health's Capital Expenditures is $36.2 million, which was down 59.63% from $31.2 million recorded in Q2 2025.
  • In the past 5 years, Sotera Health's Capital Expenditures registered a high of $71.7 million during Q4 2022, and its lowest value of $16.1 million during Q3 2021.
  • For the 5-year period, Sotera Health's Capital Expenditures averaged around $40.3 million, with its median value being $36.4 million (2024).
  • As far as peak fluctuations go, Sotera Health's Capital Expenditures skyrocketed by 14210.07% in 2022, and later crashed by 4291.2% in 2025.
  • Quarter analysis of 5 years shows Sotera Health's Capital Expenditures stood at $41.3 million in 2021, then skyrocketed by 73.85% to $71.7 million in 2022, then fell by 9.63% to $64.8 million in 2023, then grew by 1.61% to $65.9 million in 2024, then tumbled by 45.09% to $36.2 million in 2025.
  • Its Capital Expenditures stands at $36.2 million for Q3 2025, versus $31.2 million for Q2 2025 and $19.9 million for Q1 2025.